Dievini, DE

dievini Hopp Biotech Holding is a German company dedicated to the support and coaching of life and health sciences companies.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Dievini, DE Information

Geographic Data

Dievini, DE headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Dievini is an active investor in Life and Health Sciences companies and is dedicated to the coaching and support of the management teams in corporate and business development. Dievini’s focus is on innovative therapeutics and diagnostics, which are shown to lead to novel treatment regimens allowing doctors to treat patients with life-threatening diseases better and safer than they can today. Dievini, therefore, is largely invested in companies with unique and first-in-class diagnosis and therapy approaches. The indication focus is in oncology, neurology, infectious diseases, cell therapy and drug delivery systems. In molecular diagnostics, the primary focus is on systems and products in personalized medicine to support and allow individually improved therapy success with reduced adverse events. Dievini’s activities are geographically centered in Germany and Europe. The companies invested in are actively supported in their global development and business activities by dievini.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
11/2015 Molecular Health Private Equity Round 0
4/2008 Apogenix Series B 42.9M
11/2015 CureVac Series F 0
2/2012 Apogenix Series C 10.1M
7/2014 immatics biotechnologies Series D 0
4/2020 Heidelberg Pharma AG Post-IPO Equity 0
10/2018 Novaliq Series F 0
4/2013 Novaliq Series E 18.2M
9/2012 CureVac Series D 104.4M
3/2020 immatics biotechnologies Post-IPO Equity 0
10/2013 immatics biotechnologies Series D 16.2M
10/2017 immatics biotechnologies Series E 58M
1/2014 AC Immune Series D 0
1/2020 Heidelberg Pharma AG Post-IPO Equity 0
5/2010 CureVac Series C 34.9M
5/2012 Novaliq Series D 5.1M
7/2011 Novaliq Series C 3.3M
9/2010 immatics biotechnologies Series C 71.2M
4/2022 Novaliq Venture Round 0
4/2022 Novaliq Venture Round 0
4/2020 Heidelberg Pharma AG Post-IPO Equity 0
3/2020 immatics biotechnologies Post-IPO Equity 0
1/2020 Heidelberg Pharma AG Post-IPO Equity 0
10/2018 Novaliq Series F 0
10/2017 immatics biotechnologies Series E 0
11/2015 Molecular Health Private Equity Round 0
11/2015 CureVac Series F 0
7/2014 immatics biotechnologies Series D 0
1/2014 AC Immune Series D 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research